News

Leiden Collaboration Supports Development of Vaccine Against Coronavirus

De afdeling Medische Microbiologie van het Leids Universitair Medisch Centrum (LUMC) gaat de werking onderzoeken van een nieuw experimenteel vaccin tegen het coronavirus. Het onderzoek vindt plaats in samenwerking met het Leidse farmaceutische bedrijf Janssen, de ontwikkelaar van het kandidaat-vaccin.
 Leiden Collaboration Supports Development of Vaccine Against Coronavirus

Blackstone and Alnylam Enter into $2 Billion Collaboration

Blackstone and Alnylam Pharmaceuticals have entered into a broad strategic collaboration under which Blackstone will provide up to $2 billion to support Alnylam’s advancement of innovative RNA interference (RNAi) medicines that have the potential to transform the lives of patients suffering from a range of debilitating diseases.
Blackstone and Alnylam Enter into $2 Billion Collaboration

Ton de Boer (CBG) about Faster Trajectory of Vaccine Development

Ton de Boer, voorzitter van het College ter Beoordeling van Geneesmiddelen, vertelt in een nieuwsuitzending van BNR over de mogelijkheden om het proces van vaccinontwikkeling te versnellen, zonder concessies te doen aan de veiligheid.
Ton de Boer (CBG) about Faster Trajectory of Vaccine Development

Just Launched: Year in Preview 2020

Get a recap of the most important developments in the Dutch Life Sciences & Health sector and read what 2020 has to offer. Get inspired by the interviews that highlight the challenges of and opportunities for the realisation of the Health & Care missions, drawn up for the new mission-driven top sectors and innovation policy.
Just Launched: Year in Preview 2020

Funding Opportunities COVID-19 Research

COVID calls come and go quickly these days. Ttopstart keeps you up-to-date on COVID funding opportunities in this overview.
Funding Opportunities COVID-19 Research

Janssen Expects Clinical Research Corona Vaccine to Start in September

Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between Janssen and the Biomedical Advanced Research and Development Authority (BARDA); and the rapid scaling of the Company’s manufacturing capacity with the goal of providing global supply of more than one billion doses of a vaccine.
Janssen Expects Clinical Research Corona Vaccine to Start in September

MIT COVID-19 Challenge

You are invited to attend the MIT COVID-19 Challenge event, Beat the Pandemic, a series of virtual hackathons. The next event is April 3-5, 2020. In this 48-hour virtual event, we will help tackle the most critical unmet needs caused by the COVID-19 outbreak.
MIT COVID-19 Challenge

Temporary IC units due to COVID-19

Sinds enkele weken dienen de Nederlandse ziekenhuizen als decor voor de strijd tegen COVID-19. Op de Intensive Care (IC) stijgt het aantal coronapatiënten sneller dan het aantal IC-bedden. De capaciteit van de huidige 1150 beschikbare IC-bedden zal naar verwachting van het RIVM op korte termijn veel te weinig zijn. Gortemaker Algra Feenstra (GAF) heeft in samenwerking met Interflow een plan opgesteld voor het realiseren van tijdelijke IC-plaatsen.
Temporary IC units due to COVID-19

Special Announcement COVID-19

Top Sector Life Sciences & Health (Health~Holland) intends to invest in the field of COVID-19. If you have a high end public-private research proposal in the field of COVID-19, we are inviting you to send us an e-mail.
Special Announcement COVID-19

Health-RI Facilitating COVID-19 Research

Health-RI launched the Dutch Covid-19 Research Data Support Programme. To support investigators and health care professionals with tools and services in their search for ways to overcome the pandemic and its health consequences.
Health-RI Facilitating COVID-19 Research